Trivalent DNA vaccine + pPJV2012

A trivalent DNA vaccine is a type of genetic immunization that uses plasmid DNA encoding antigens from three different strains or types of a pathogen to induce an immune response. The "pPJV2012" component refers to a specific plasmid vector used in the formulation. These vaccines work by delivering engineered circular DNA (plasmids) into host cells, which then express the encoded antigens and stimulate both humoral and cellular immunity. Trivalent DNA vaccines are being developed for various infectious diseases and potentially for chronic conditions, leveraging their ability to elicit targeted immune responses without using live pathogens or traditional adjuvants[2][6]. The mechanism involves cellular uptake of the plasmid, antigen expression, and subsequent activation of the immune system against those antigens. Technovalia is a developer involved in recent studies using this platform.